One sentence summary: Iron chelation is able to potentiate the antibacterial activity of antibiotics by destroying bacterial biofilms which makes this combination a promising strategy for the treatment of chronic device-related infections. Editor: Tom Coenye † Débora C. Coraç a-Huber, http://orcid.org/0000-0001-7664-5989
INTRODUCTION
Coagulase-negative staphylococci (CNS) account for the majority of foreign body-related infections (Becker, Heilmann and Peters 2014 ) but often such bacteria have a reduced susceptibility or even resistance to conventional antibiotics (Hoyle and Costerton 1991; Giormezis et al. 2014; Benito et al. 2016) . One additional mechanism contributing to this phenomenon and negatively affecting the antimicrobial susceptibility of CNS is the potential of these bacteria to produce biofilms when attached to foreign body surfaces (Giormezis et al. 2014; Benito et al. 2016) . Biofilm formation enables bacteria in general to resists and survive under conditions with limited access to nutrients or in hostile environments (Hoyle and Costerton 1991) . The ability to form biofilms equips certain bacteria with the capacity to cause chronic medical device-associated infections. Biofilm formation also explains why some normal flora organisms traditionally considered 'a-pathogenic' become virulent when they grow in the presence of foreign bodies (Tande and Patel 2014) . The presence of biofilm results in tolerance of bacteria to antibiotics because many of them cannot sufficiently penetrate through biofilms (Singh et al. 2010; Brauner et al. 2016) .
Iron is an essential element for both eukaryotes and prokaryotes because it is involved in many central metabolic processes, and a sufficient supply of iron is central for cellular proliferation and growth. Thus, the control over iron homeostasis is considered to be a central battlefield in host-pathogen interaction and infection (Soares and Weiss 2015) . Bacteria such as staphylococci have developed iron acquisition systems to guarantee a sufficient supply of iron needed for their growth and proliferation. These iron acquisition systems include cell-surfaceassociated heme-iron extraction and transfer mechanisms to obtain heme from hemoproteins, the production of high-affinity iron scavenging siderophores to capture iron from transferrin and lactoferrin, and ferric iron reductases and transporters for the acquisition of free inorganic iron (Sheldon and Heinrichs 2015) . A sufficient availability of iron is not only linked to bacterial growth and pathogenicity, but iron also plays an important role in the biofilm formation process (Lin et al. 2012; Farrand et al. 2015) .
Iron restriction strategies can limit the growth of bacteria in vitro and in vivo (Luo et al. 2014; Lebeaux et al. 2015; Liu et al. 2017) . Iron availability for bacteria can be restricted upon application of iron chelators that impair microbial proliferation (Neupane and Kim 2009; Thompson et al. 2012; Nairz et al. 2013) . There are three classes of iron chelators currently available for clinical application. Deferiprone (DFP), as a bi-dentate chelator, and desferasirox that is a tri-dentate molecule, do not bind all six sites on the iron molecule capable of catalyzing free radical reactions. In contrast, deferoxamine is a hexa-dentate molecule capable of binding to all six iron coordination sites (Ma et al. 2012; Horwitz and Horwitz 2014) . DFP has a good tissue penetration (Thompson et al. 2012 ), a certain antimicrobial activity (Kontoghiorghes et al. 2010; Visca et al. 2013; Ma, Gao and Maresso 2015; Gokarn and Pal 2018) and has also been shown to transport iron among cellular compartments (Sohn et al. 2011) . In addition to affecting the growth of bacteria, iron chelators may also impact on irondependent biofilm formation and thereby improve the therapeutic efficacy of antibiotics by promoting their penetration.
To study this hypothesis we used a model of titanium discs colonized with biofilm forming CNS. We examined the effects of DFP, three antibiotic classes alone and combination thereof towards biofilm stability and antimicrobial efficacy.
MATERIAL AND METHODS

Bacterial strains
Staphylococcus epidermidis (ATCC 12228) and a CNS (S. epidermidis) isolated from an implant-related infections patient were used in this study. The strains were suspended in Mueller-Hinton bouillon to a Mc Farland (McF, Mc Farland Densitometer, Den 1B, Grant Instruments (Cambridge) Ltd, Shepreth, GB) turbidity of 0.5 (1.5 × 10 8 CFU/mL).
Antibiotics
Gentamicin (gentamicin sulphate, dry powder, Heraeus Medical GmbH, Wehrheim, Germany), clindamycin (clindamycin phosphate, Dalacin-C R Phosphat (600 mg/4 mL), Pfizer Corporation Austria GmbH, Vienna, Austria) and vancomycin (vancomycin hydrochloride, Vancocin R (1g dry powder), AstroPharma GmbH, Vienna, Austria) were used. The concentration used for each antibiotic is described in Table 1 .
Iron chelator
As iron chelator we used the commercially available and clinically used compound DFP (Sigma Aldrich, St. Louis, MI, USA), a 10 mM stock solution was stored at −20 • C and a 25 μM working solution was prepared prior to the tests upon dilution with phosphate buffered saline (PBS, 9.55 g/l Dulbecco, Lonza). We chose to treat the biofilms first with DFP for 6 h and subsequently treat the biofilms with the antibiotics for 24 h. This treatment simulates an adequate clinical treatment where DFP would be applied locally by using, for example, a vacuum system direct in the wound and afterwards the patient would be systemically treated with the adequate antibiotic compound.
Establishment of iron chelator doses
To find an appropriate dose of DFP for subsequent experiments we exposed S. epidermidis ATCC 12228 and the CNS clinical isolate to different concentrations of DFP. For generation of biofilms 2 mL of bacterial suspensions (1.5 × 10 8 CFU/mL) of each strain were grown on multi-wells plates (VWR R , Radnor. Pennsylvania, USA). The plates were incubated on a shaker (Edmund Bühler GmbH, Hechingen, Germany) at 37
• C (30 cycles/min) for 72 h for the obtainment of biofilms. The growth medium was not changed during this period. Thereafter, the media containing the bacteria were removed and the wells were washed with PBS for the removal of planktonic cells. All the wells containing biofilm were incubated with different concentrations of DFP (2.5, 25 and 250 μM) dissolved in 1 mL of medium at 37 • C for 6 h. After incubation the wells were washed in PBS once, fresh PBS was added and the plates were sonicated for 1 min at high intensity (Bactosonic, Bandelin electronic GmbH & Co. KG, Berlin, Germany). After sonication the fluid was transferred to a Mueller-Hinton agar plate (10 μL) and incubated for 24 h at 36 • C. After incubation the number of colony forming units (CFU) was defined ( Fig. 1 ). The control wells were sonicated after the incubation of the biofilms with DFP and the CFU was counted.
Antibiotic susceptibility tests
Standard susceptibility tests for the estimation of minimal inhibitory concentration (MIC) of the antibiotics were carried out Figure 1 . Effects of increasing DFP dosages on two isolates of S. epidermidis in vitro (average/SD). The CFU for the control group is significantly higher than all DFP treated groups. Staphylococcus epidermidis ATCC 12228 (P < 0.0001); CNS patient isolate (P < 0.005). The experiment was carried out in technical triplicate.
using E-test stripes (bioMérieux Austria GmbH, Vienna, Austria).
The bacterial strains were plated on Mueller-Hinton agar plates (10 μL of 1.5 × 10 8 CFU/mL solution) with a sterile loop and after-
wards the E-test stripes for each antibiotic (Lannacher Heilmittel GmbH, Lannach, Austria) were placed on the plates. The plates were incubated at 37
• C for 24 h. After incubation the zones of inhibition were read from each stripe for the obtainment of MIC. The estimation of MIC for each antibiotic helped us establish the concentration used for subsequent experiments.
Biofilm growth
The bacterial suspensions were incubated on sterile titanium alloy discs (TiMo12Zr6Fe2, diameter 7 mm; Stryker GmbH & Co KG, Duisburg, Germany) to allow for biofilm formation. Specifically, 2 mL of bacterial suspension (1.5 × 10 8 CFU/mL) of each strain was added to different multi-well plates (VWR R , Radnor. Pennsylvania, USA) containing sterile titanium discs. The plates containing the inoculated discs were incubated under humidity control on a shaker (Edmund Bühler GmbH, Hechingen, Germany) at 37
• C (30 cycles/min) for 72 h for the obtainment of biofilms. The growth medium was not changed during this period.
CFU quantification
After the growth of the biofilms, the discs containing bacteria with biofilms were removed from the media and washed in PBS for the removal of planktonic cells. The discs were then placed in a new multi-well plate (VWR R , Radnor. Pennsylvania, USA) containing fresh Mueller-Hinton medium. The discs containing biofilm were incubated in 1 mL of 25 μM of DFP for 6 h at 37
• C or medium serving as control. As control the discs containing biofilms were also treated with 1 mL of 25 μM of ferric chloride or concomitantly with 25 μM of ferric chloride and 25 μM of DFP. After the incubation with DFP or control the discs were exposed to antibiotic treatment. For the antibiotic treatment the discs were incubated with gentamicin, clindamycin and vancomycin at the indicated dosages (section 2.2) at 37
• C for 24 h. After that the discs were washed in PBS once and sonicated in fresh PBS for 1 min at high intensity (Bactosonic, Bandelin electronic GmbH & Co. KG, Berlin, Germany). The sonication fluid was transferred to a Mueller-Hinton agar plate (10 μL) and incubated for 24 h at 37
• C. After incubation the number ofCFU was determined.
Fluorescence microscopy
A Live/Dead Double Staining Kit (EMD Millipore Corporation, San Diego, USA) for determination of bacterial viability was used. The staining solution was prepared in a 2 mL Eppendorf tube. The 1 mL PBS was mixed with 1 μL solution A (1 mM Cyto-Dyecalcein AM) and 1 μL solution B (2.5 mg/mL propidium iodide). The solution was then covered with aluminium foil to protect from light. The biofilms were grown in a microtiter plate containing glass discs (cover slips: 12 mm) with 2 mL of an inoculum of S. epidermidis ATCC 12228 and the CNS in Mueller-Hinton medium (McF turbidity of 0.5 each). Here cover slips were used instead of metal discs to allow the microscopy of the biofilms by fluorescence light microscopy. The discs were incubated for 72 h at 37
• C in a moist chamber in an incubator shaker. After incubation, the discs containing biofilm were incubated in 1 mL of 25 μM of DFP for 6 h at 37
• C or medium serving as control. After the incubation with DFP or control the discs were exposed to antibiotic treatment. For the antibiotic treatment the discs were incubated with gentamicin, clindamycin and vancomycin at the indicated dosages at 37
• C for 24 h. After the treatment with antibiotics, the discs were washed with PBS for the removal of planktonic cells and were covered with the staining solution and placed upside down on glass slides. The slides were incubated in darkness for 15 min at 37
• C. The fluorescence microscopy was done with an Axio Scope A1 (Carl Zeiss Microscopy GmbH, Jena, Germany) and images were captured by an AxioCamERc 5s (Carl Zeiss Microscopy GmbH, Jena, Germany). Fluorescence from propidium iodide was detected using a filter with excitation wavelength of 540-580 nm and an emission filter of 600-660 nm. Fluorescence from Cyto was detected using a filter with excitation wavelength of 465-495 nm and an emission filter of 515-555 nm.
Scanning electron microscopy
After biofilm growth and subsequent treatments, the discs were removed from media, washed for removal of planktonic cells and treated in 1 mL glutaraldehyde 2.5% for fixation. After fixating for 24 h at 4
• C, the discs were dehydrated with an ascending alcohol series (50%-70%-80%-99.9% ethanol). Each step lasted for 5 min. After the last step the discs were placed in an incubator at 37
• C for 1 h. The dried discs were placed on aluminum pins and fixed with conductive carbon cement (Leit-C; Göcke, Plano GmbH, Wetzlar, Germany). The pins were sputtered with gold (Agar Sputter Coater, Agar Scientific Ltd, Stansted, GB) for 1 min, thickness 10 nm approximately and analyzed by scanning electron microscopy (SEM, JSM-6010LV, JEOL GmbH, Freising, Germany).
Data analysis
The results were evaluated by using GraphPad Prism 7.00 (GraphPad Software, Inc., La Jolla, CA, USA 
RESULTS AND DISCUSSION
Susceptibility tests
The MICs for gentamicin, clindamycin and vancomycin for S. epidermidis ATCC 12228 strains and a clinical isolate of CNS are shown in Table 1 . These MICs were then used for the subsequent combination experiments with DFP.
Establishment of iron chelator doses
We then investigated the antibacterial effects of increasing dosages of DFP towards biofilm producing bacterial strains. Whereas exposure of S. epidermidis ATCC 12228 to DFP resulted in a moderate, dose-dependent reduction of biofilm formation already at a concentration of 2.5 μM, this effect was only weak with the clinical isolate of CNS and not increased by escalating dosages of DFP (Fig. 1) . We thus chose the dosage of 25 μM DFP for subsequent in vitro experiments (range 10-400 μM). The results were statistically analysed with two-way ANOVA and Bonferroni's multiple comparisons test.
Combined effects of iron chelation and antibiotics
As control the discs containing biofilms were also treated with ferric chloride and concomitantly with ferric chloride and DFP. This treatment showed that the effect of DFP can be over-come by concomitant addition of iron to the medium ( Fig. 2A and  B) . We then studied the effect of antibiotics with/without DFP on bacterial proliferation in vitro. The addition of antibiotics at MIC as well as DFP application when used alone resulted in a significant reduction of both bacterial isolates by several logs, however, no complete killing was observed. After exposure of biofilm producing bacteria to 25 μM of DFP for 6 h prior to the treatment with the antibiotics, a complete elimination of bacteria was observed for the S. epidermidis ATCC 12228 ( Fig. 2A) . We also found a significant reduction in bacterial numbers for the clinical CNS isolate (from 10 7 to 10 3 CFU/μL) upon combined treatment with DFP and antibiotics as compared to sole treatment with the respective compounds (Fig. 2B ). This indicated that the addition of the iron chelator DFP amplified the antibacterial activity of conventional antibiotics against S. epidermidis. Our results are in good agreement with observations made with biofilm producing Pseudomonas aeruginosas using the metal chelator ethylenediamine tetraacetic acid (EDTA) [14] . Similarly, EDTA enhanced the antimicrobial activity of selected antibiotics against strains isolated from infected intravascular catheters (Lebeaux et al. 2015) . While our studies in addition highlight the importance of the specific chelation of iron we provide further details on the underlying mechanisms of this synergistic effect by disrupting biofilm integrity. Gokarn and Pal (2018) hypothesized that iron deprivation caused by iron chelators in bacteria may result in inhibition or inactivation of proteins and enzymes involved in vital functions. Siderophores may increase the biofilm permeability by scavenging iron thereby increasing the bacteria's antibiotic susceptibility (Gokarn and Pal 2018) . Hypothesizing that altering bacterial iron homeostasis could help developing new antimicrobial strategies, Ma, Gao and Maresso (2015) found that E. coli is eliminated by sub-lethal doses of antibiotics when combined with the iron chelator DFP. This process is associated with increased permeability of the outer bacterial membrane, with an iron starvation response of bacteria, as measured by upregulation of the ferric uptake regulator Fur, and a rise in the level of intracellular oxygen radicals (Ma, Gao and Maresso 2015) .
Effect of combination therapy on biofilm integrity
We then performed fluorescence staining for investigating the effects of single and combined treatments on biofilm integrity and the presence of live/dead bacteria. Biofilm producing bacteria residing on titanium discs treated with DFP prior to antibiotic exposure showed more dead bacteria (red areas) as compared to biofilms treated with antibiotics alone. Staphylococcus epidermidis ATCC 12228 cultivated under control conditions showed formation of biofilms, which cover the complete surface of cover slips (Fig. 3A) . All live bacteria were stained in green to show viability. The same could be observed for biofilms formed by the patient isolate; here the biofilms were formed as clumps of live bacteria (Fig. 3B) . The biofilms treated with 25 μM of DFP resulted in impaired growth and more dead bacteria for both strains ( Fig. 3C  and D) . Staphylococcus epidermidis ATCC 12228 biofilms treated with gentamicin showed less live bacteria (Fig. 3E ) in contrast to biofilms cultivated from the patient CNS strain. Here the biofilms were massive and no dead bacteria were observed (Fig. 3F) . Clindamycin was effective against S. epidermidis ATCC 12228 (Fig. 3G ) resulting in reduced biofilm growth and partial bacterial killing as reflected by the red areas. The same could be observed on the image of the CNS patient isolate (Fig. 3H ). Vancomycin exposure caused killing of S. epidermidis ATCC 12228 biofilms (Fig. 3I) , but only to a limited extend with the patient isolate of CNS (Fig. 3J) . The combination of DFP and antibiotics showed more profound effects on the killing of bacteria residing within biofilms. Gentamicin treatment combined with DFP showed more dead S. epidermidis (Fig. 3K) and CNS (Fig. 3L ) in comparison to gentamicin alone ( Fig. 3E and F) . The same could be observed for the combination of clindamycin and DFP ( Fig. 3M and N) as well as for vancomycin plus DFP ( Fig. 3O and P) .
To further verify the effects of single and combined therapies observed upon CFU quantification and fluorescence microscopy, we next performed SEM of bacterial biofilms placed on titanium cover slips. The control groups showed biofilm growth for both strains. Massive biofilms showing channels and slime formation were observed for both strains. Staphylococcus epidermidis ATCC 12228 showed larger and more structured biofilms (Fig. 4A ) in comparison to the patient isolate that presented with small slime-rich islands containing the biofilms (Fig. 4B) . The treatment with DFP did not allow the growth of massive biofilms. In this case only small biofilms were observed in S. epidermidis ATCC 12228 cultures (Fig. 4C ) and the CNS patient isolate (Fig. 4D) . In contrast to the samples treated with DFP alone, the samples treated with iron or iron plus DFP showed more biofilm formation. In these cases cluster of cells was observed distributed on the surface of the discs (Fig. 4E and H) . Little biofilm formation was observed on the strains treated with gentamicin ( Fig. 5A and B) in comparison to the control groups. In the groups treated with clindamycin alone, small biofilms could be observed for both strains (Fig. 5C and D) , whereas only minimum biofilm formation could be observed in the groups treated with vancomycin. In this latter case, still some small biofilms or free cells could be observed on the surface of the discs ( Fig. 5E and F) . In comparison to the strains treated with gentamicin alone, the strains treated with the combination of gentamicin and DFP hardly any biofilm formation was evident ( Fig. 6A and B) . Complete killing of bacteria and biofilm disruption was achieved by combined treatment of DFP with either clindamycin (Fig. 6C and D) or vancomycin ( Fig. 6E and F) . These results, as well as the results of fluorescence staining (above) on biofilm integrity, strongly suggest that iron chelator treatment enhances the susceptibly of biofilm forming staphylococci to conventional antibiotics that can be largely explained by disruption of biofilm formation by the iron chelator which then enables a better penetration of antibiotics into bacteria with subsequent promotion of bacterial killing. In addition, a direct, albeit smaller antibacterial effect of iron chelators due to limitation of bacterial iron availability may also play a role in this setting and may further contribute to the synergistic action of DFP and antibiotics (Cassat and Skaar 2013; Weiss and Carver 2018) .
Our study thus indicates that the combination of the iron chelator DFP with conventional antibiotics can potentiate their antimicrobial activity towards biofilm producing CNS placed on titanium cover slips. We found that this interaction leads to a disruption of biofilms that likewise increases the penetration of antibiotics into bacteria where they can fulfill their antimicrobial activity. From our data it is suggestive that such a combination may be of benefit to eliminate bacteria residing on implanted devices that would be of enormous clinical benefit because bacterial biofilm formation on such surfaces is often associated with clinical failure of antibiotic therapies resulting in the need for surgical revision (Sendi and Zimmerli 2012) . Iron chelators have been used to treat iron overload disorders for many years, and their pharmacological and safety profiles are well known (Hershko et al. 2005; Kovacevic et al. 2010) . As iron is essential for bacterial growth and also involved in biofilm formation, the combination of iron chelation with antibiotic therapy may be safe and enhance the antimicrobial efficacy of antibiotics to eliminate biofilm producing bacteria on implanted devices; a hypothesis that has to be confirmed in vivo by using animal models of device related infections.
